Skip to main content

Main menu

  • Home
  • About
    • About CBM
    • Editorial Board
    • Announcement
  • Articles
    • Ahead of print
    • Current Issue
    • Archive
    • Collections
    • Cover Story
  • For Authors
    • Instructions for Authors
    • Resources
    • Submit a Manuscript
  • For Reviewers
    • Become a Reviewer
    • Instructions for Reviewers
    • Resources
    • Outstanding Reviewer
  • Subscription
  • Alerts
    • Email Alerts
    • RSS Feeds
    • Table of Contents
  • Contact us
  • Other Publications
    • cbm

User menu

  • My alerts

Search

  • Advanced search
Cancer Biology & Medicine
  • Other Publications
    • cbm
  • My alerts
Cancer Biology & Medicine

Advanced Search

 

  • Home
  • About
    • About CBM
    • Editorial Board
    • Announcement
  • Articles
    • Ahead of print
    • Current Issue
    • Archive
    • Collections
    • Cover Story
  • For Authors
    • Instructions for Authors
    • Resources
    • Submit a Manuscript
  • For Reviewers
    • Become a Reviewer
    • Instructions for Reviewers
    • Resources
    • Outstanding Reviewer
  • Subscription
  • Alerts
    • Email Alerts
    • RSS Feeds
    • Table of Contents
  • Contact us
  • Follow cbm on Twitter
  • Visit cbm on Facebook

Table of Contents

March 01, 2014; Volume 11,Issue 1

Review

  • You have access
    Cancer metabolic reprogramming: importance, main features, and potentials for precise targeted anti-cancer therapies
    Liem Minh Phan, Sai-Ching Jim Yeung and Mong-Hong Lee
    Cancer Biology & Medicine March 2014, 11 (1) 1-19; DOI: https://doi.org/10.7497/j.issn.2095-3941.2014.01.001
  • You have access
    Mechanistic considerations for the use of monoclonal antibodies for cancer therapy
    Patrick M. Glassman and Joseph P. Balthasar
    Cancer Biology & Medicine March 2014, 11 (1) 20-33; DOI: https://doi.org/10.7497/j.issn.2095-3941.2014.01.002
  • You have access
    pH-responsive mesoporous silica nanoparticles employed in controlled drug delivery systems for cancer treatment
    Ke-Ni Yang, Chun-Qiu Zhang, Wei Wang, Paul C. Wang, Jian-Ping Zhou and Xing-Jie Liang
    Cancer Biology & Medicine March 2014, 11 (1) 34-43; DOI: https://doi.org/10.7497/j.issn.2095-3941.2014.01.003

Original Article

  • You have access
    Inhalation treatment of lung cancer: the influence of composition, size and shape of nanocarriers on their lung accumulation and retention
    Olga B. Garbuzenko, Gediminas Mainelis, Oleh Taratula and Tamara Minko
    Cancer Biology & Medicine March 2014, 11 (1) 44-55; DOI: https://doi.org/10.7497/j.issn.2095-3941.2014.01.004
  • You have access
    Uptake of prostate cancer screening and associated factors among Chinese men aged 50 or more: a population-based survey
    Winnie K.W. So, Kai Chow Choi, Winnie P.Y. Tang, Paul C.W. Lee, Ann T.Y. Shiu, Simone S.M. Ho, Helen Y.L. Chan, Wendy W.T. Lam, William B. Goggins and Carmen W.H. Chan
    Cancer Biology & Medicine March 2014, 11 (1) 56-63; DOI: https://doi.org/10.7497/j.issn.2095-3941.2014.01.005
  • You have access
    Interferon-alpha-2b induces autophagy in hepatocellular carcinoma cells through Beclin1 pathway
    Jun Zhao, Ming-Li Wang, Zeng Li, Dong-Mei Gao, Yu Cai, Jun Chang and Shi-Ping Wang
    Cancer Biology & Medicine March 2014, 11 (1) 64-68; DOI: https://doi.org/10.7497/j.issn.2095-3941.2014.01.006
Back to top
PreviousNext

In this issue

Cancer Biology and Medicine: 11 (1)
Cancer Biology & Medicine
Vol. 11, Issue 1
1 Mar 2014
  • Table of Contents
  • Index by author

Submit

Sign up for alerts

Jump to

  • Review
  • Original Article

  • Top Topics
  • Most Cited
  • Most Read
Loading
The advanced development of molecular targeted therapy for hepatocellular carcinoma
The efficacies and biomarker investigations of anti-programmed death-1 (anti-PD-1)-based therapies for metastatic bone and soft tissue sarcoma
Immunology and immunotherapy in breast cancer
Effects of menopausal hormone therapy-based on the role of estrogens, progestogens, and their metabolites in proliferation of breast cancer cells
Breast cancer screening and early diagnosis in Chinese women
Is adjuvant chemotherapy necessary for early gastric cancer?
Modulating microRNAs in cancer: next-generation therapies
Safety and efficacy of anti-EGFR monoclonal antibody (SCT200) as second-line therapy in advanced esophageal squamous cell carcinoma
Personalized immunotherapy in cancer precision medicine
Cellular immunotherapy for hematological malignancy: recent progress and future perspectives

Navigate

  • Home
  • Current Issue

More Information

  • About CBM
  • About CACA
  • About TMUCIH
  • Editorial Board
  • Subscription

For Authors

  • Instructions for authors
  • Journal Policies
  • Submit a Manuscript

Journal Services

  • Email Alerts
  • Facebook
  • RSS Feeds
  • Twitter

 

© 2026 Cancer Biology & Medicine

Powered by HighWire